News Release: July 27, 2025
Ethyl 2-Bromopropionate Price, Production, Latest News and Developments in 2025
In 2025, the global chemical industry has seen dynamic changes, and among the specialty chemicals gaining attention is Ethyl 2-bromopropionate. The compound, extensively used as an intermediate in pharmaceuticals, agrochemicals, and fine chemical syntheses, has experienced significant price volatility, production shifts, and trade flow transformations. This news-based press release provides a comprehensive outlook on Ethyl 2-bromopropionate price trends, production developments, sales volumes, and global trade updates.
For more insights, refer to this detailed Ethyl 2-bromopropionate price trend and production News
Ethyl 2-Bromopropionate Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
The Ethyl 2-bromopropionate price trend over the past five years has reflected the broader volatility in the chemical industry. In 2019, average global prices hovered around $2,800/MT. During this period, stable raw material costs and consistent demand from pharmaceutical intermediates supported this pricing.
In 2020, the COVID-19 pandemic caused disruptions in supply chains, leading to temporary shortages and increased logistical costs. The average price rose to approximately $3,150/MT by Q3 of that year, driven by constrained shipments from China and India—the two largest producers.
In 2021, supply chains began to stabilize, but the soaring freight costs continued to keep the Ethyl 2-bromopropionate price news on an upward trajectory. Prices saw an average of $3,400/MT throughout the year. However, the second half of 2021 observed a slight easing in raw material costs due to improved inventories of ethanol and brominating agents.
2022 saw a slight dip in prices, particularly in Q2 and Q3, with average levels reaching around $3,200/MT. This was largely attributed to increased domestic production in Southeast Asia and new entrants in Eastern Europe. Nevertheless, environmental regulations in China led to the closure of smaller unregulated units, slightly tightening the supply toward the year-end.
In 2023, macroeconomic uncertainty, including inflation and fuel price hikes, led to increased production costs. Ethyl 2-bromopropionate price trends once again showed an upward shift, peaking at $3,600/MT in Q4. Supply issues in China, due to power rationing, further exacerbated the pricing environment.
Looking ahead into 2024, the Ethyl 2-bromopropionate price trend reflected mixed sentiments. While Q1 and Q2 prices averaged $3,550/MT, Q3 and Q4 saw prices slightly decline to $3,420/MT and $3,300/MT respectively, due to increased output in India and revived exports from South Korea.
The overall price trajectory from 2019 to 2024 clearly shows sensitivity to raw material prices, production cost volatility, government regulations, and global shipping dynamics. A combination of these factors will continue to influence Ethyl 2-bromopropionate price news updates into 2025.
Ethyl 2-Bromopropionate Price Trend Quarterly Update in $/MT (2025 Forecast)
The estimated quarterly Ethyl 2-bromopropionate price forecast for 2025 shows the following trend:
- Q1 2025: $3,280/MT
- Q2 2025: $3,370/MT
- Q3 2025: $3,460/MT
- Q4 2025: $3,520/MT
The slight upward trend reflects a recovery in demand for fine chemicals and intermediates, particularly from the agrochemical sector in North America and Europe. Ethyl 2-bromopropionate sales volume is expected to increase in the second half of 2025, primarily driven by rising orders from pharmaceutical manufacturers resuming post-COVID product launches.
Production costs remain sensitive to bromine and ethanol pricing, with minor fluctuations expected due to energy price adjustments in Asia. Moreover, planned plant upgrades in India and China during mid-2025 might momentarily limit output, contributing to a tighter supply situation and minor price increases in Q3 and Q4.
Global Ethyl 2-Bromopropionate Import-Export Business Overview
Ethyl 2-bromopropionate has established itself as a widely traded compound due to its versatile industrial applications. The global import-export landscape for this chemical has experienced substantial evolution in recent years. Key exporting nations include China, India, and South Korea, while major importers span across North America, Western Europe, Southeast Asia, and parts of the Middle East.
In 2023, China accounted for nearly 45% of the global Ethyl 2-bromopropionate exports. However, due to tightening environmental standards and an energy crisis in the latter half of 2023, production capacities were marginally reduced. This impacted exports in early 2024. In contrast, India ramped up production facilities in Gujarat and Maharashtra, allowing it to emerge as a secondary hub for Ethyl 2-bromopropionate production.
India’s export volume in 2024 reached approximately 5,000 MT, a 22% increase compared to 2022. Ethyl 2-bromopropionate sales volume from Indian manufacturers to Europe increased notably, filling the temporary void left by reduced Chinese exports. South Korea also witnessed a marginal boost in export activity due to increased synthesis capacities developed in late 2022.
North America remained the single largest importing region in 2024, with a demand of over 7,000 MT, primarily utilized in pharmaceutical intermediate synthesis. The U.S., in particular, has been relying on imports to meet domestic demand due to limited domestic manufacturing of brominated esters. The increase in regulatory stringency in chemical imports has, however, led to delays and additional testing requirements for imported lots.
The European market, led by Germany, France, and the Netherlands, observed stable imports of Ethyl 2-bromopropionate, with combined volumes reaching around 4,500 MT in 2024. Growth in demand is expected from agrochemical formulation industries in 2025, contributing to increased orders.
Meanwhile, Southeast Asia, including Vietnam and Thailand, has increased its imports owing to expanding agrochemical manufacturing. Despite smaller volumes than North America and Europe, the region is witnessing growth exceeding 6% CAGR in Ethyl 2-bromopropionate imports since 2021.
Importers have been cautious about pricing and origin, focusing on sourcing from compliant, high-quality producers. Thus, transparency in Ethyl 2-bromopropionate production practices and traceability have become essential to maintaining business in developed markets.
Exporters are leveraging Free Trade Agreements (FTAs) to reduce import duties and promote their Ethyl 2-bromopropionate sales volume in target countries. The Indo-EU and RCEP agreements have provided competitive pricing advantages to Asian exporters.
With production capacity expansion plans announced by key Indian and South Korean firms in early 2025, Ethyl 2-bromopropionate export volumes are expected to increase by 10–12% in H2 2025. However, global shipping constraints and geopolitical tensions might still impact timelines and logistics costs.
Companies are increasingly integrating backward production processes to ensure supply security of raw materials such as bromine, thereby reducing external dependency and improving production cost efficiencies. This strategic move is anticipated to reduce Ethyl 2-bromopropionate price volatility in the long term.
In conclusion, the Ethyl 2-bromopropionate import-export scenario continues to evolve dynamically, influenced by production geography shifts, regulatory policies, and demand upticks from key application sectors. Stakeholders across the supply chain are closely monitoring pricing, trade barriers, and emerging technologies to maintain market competitiveness.
To explore detailed market figures, production capacity data, and request a free sample, visit the full market report here:
https://datavagyanik.com/reports/ethyl-2-bromopropionate-market-size-production-sales-average-product-price-market-share-import-vs-export/
Ethyl 2-Bromopropionate Production Trends by Geography
Ethyl 2-bromopropionate production is predominantly concentrated in a few key countries, with Asia-Pacific taking the lead in terms of output and facility expansion. The chemical, widely used as an intermediate in pharmaceutical and agrochemical manufacturing, is subject to production trends driven by feedstock availability, industrial infrastructure, regulatory landscape, and cost efficiencies.
Asia-Pacific
China continues to be the global leader in Ethyl 2-bromopropionate production. The country possesses a mature bromine extraction industry and strong industrial clusters that allow integrated production. Provinces such as Jiangsu, Shandong, and Zhejiang house large-scale facilities that manufacture brominated intermediates, including Ethyl 2-bromopropionate. Despite occasional disruptions due to environmental inspections and energy-related restrictions, China has maintained its top position due to the availability of raw materials and competitive pricing.
India is the fastest-growing producer in the Asia-Pacific region. Gujarat and Maharashtra are emerging hubs with specialized chemical zones and SEZs (Special Economic Zones) dedicated to pharmaceutical and specialty chemical production. Companies are investing in capacity enhancement and process efficiency, with an eye on exports to Europe and North America. Additionally, India’s robust ethanol production, necessary for ethyl ester synthesis, supports localized manufacturing of Ethyl 2-bromopropionate.
South Korea and Japan also play moderate roles in production. South Korea has shown interest in diversifying chemical output and investing in downstream derivatives for export. While Japan focuses on quality and process innovation, its output is limited compared to China and India.
North America
North America has limited Ethyl 2-bromopropionate production, with the United States relying heavily on imports. However, some specialized chemical producers in Texas and Louisiana produce small volumes, primarily for local pharmaceutical and research applications. Environmental regulations and the high cost of raw materials have restricted large-scale production in the region.
There is growing interest in backward integration and niche manufacturing to reduce dependency on Asian imports. Pilot-scale operations and process development initiatives are ongoing to explore domestic production feasibility.
Europe
Western Europe, particularly Germany and Switzerland, maintains small but technologically advanced production capacities. These are often tied to pharmaceutical ingredient synthesis operations. European producers focus more on high-purity production suitable for stringent quality standards, especially in pharmaceutical applications.
Despite limited production, European manufacturers rely on strategic imports from Asia while investing in high-performance intermediate processing. Regulations surrounding chemical manufacturing and brominated compounds remain tight, restricting the potential for large-scale expansion.
Eastern Europe, particularly Poland and the Czech Republic, is gradually becoming attractive for contract manufacturing due to lower labor and compliance costs compared to Western Europe. Some production has been outsourced to facilities in these countries to serve regional demand.
Middle East and Africa
Production in the Middle East is minimal but evolving. Countries like the UAE and Saudi Arabia are exploring investments in chemical production as part of economic diversification plans. Infrastructure is being developed in free trade and industrial zones, which may support Ethyl 2-bromopropionate production in the future.
Africa, on the other hand, has negligible production capabilities and remains entirely dependent on imports from Asia and Europe. However, demand is increasing due to the rising pharmaceutical and agrochemical markets, which may encourage localized manufacturing in the future.
Latin America
Brazil is the leading country in Latin America in terms of potential for chemical production. While direct production of Ethyl 2-bromopropionate is limited, the country is investing in domestic chemical infrastructure, which could lead to future opportunities. Currently, the region mostly relies on imports, especially for use in crop protection and industrial chemical sectors.
Argentina and Mexico are also potential future players. While they do not yet have major manufacturing facilities for Ethyl 2-bromopropionate, their pharmaceutical sectors show growth, potentially driving demand for localized production.
In summary, production of Ethyl 2-bromopropionate is heavily concentrated in Asia, especially China and India, due to resource availability and production cost advantages. Other regions, while limited in current capacity, are witnessing strategic shifts toward self-sufficiency, regulatory-driven diversification, and quality-driven production innovation.
Ethyl 2-Bromopropionate Market Segmentation
Key Market Segments of Ethyl 2-Bromopropionate:
- By Application
- By End-Use Industry
- By Purity Grade
- By Distribution Channel
- By Region
1. By Application
- Pharmaceutical Intermediates
- Agrochemical Intermediates
- Fine Chemical Synthesis
- Research and Development
- Specialty Formulations
Pharmaceutical intermediates form the largest application segment. Ethyl 2-bromopropionate is widely used in the synthesis of chiral molecules and active pharmaceutical ingredients (APIs). The growth of global pharmaceutical production, especially in India and China, has driven demand for this compound. Its role in creating esterified intermediates for anticancer and anti-inflammatory drugs has pushed its prominence.
Agrochemical intermediates are the second-largest segment. The compound is used to synthesize herbicides, fungicides, and growth regulators. The expansion of commercial farming across Asia and Latin America, combined with a focus on yield optimization, is fueling this segment.
The fine chemical and specialty formulation sector, though smaller in size, is growing due to increasing R&D activities and demand for niche chemical processes in Europe and North America.
2. By End-Use Industry
- Pharmaceutical Industry
- Agrochemical Industry
- Chemical Research Institutes
- Biotechnology Firms
- Contract Manufacturing Organizations (CMOs)
The pharmaceutical industry dominates the end-use classification. Ethyl 2-bromopropionate is extensively employed in the formulation of custom synthesis intermediates. CMOs increasingly utilize it for tailored projects requiring small-batch, high-purity production.
Agrochemical companies rely on this compound to build intermediates for large-scale herbicide and pesticide production. Its ability to participate in halogenation reactions makes it valuable in crop protection chemicals.
Research institutes and biotech firms use it in pilot studies, especially in compound screening and synthesis route evaluation, contributing to steady demand from the academic sector.
3. By Purity Grade
- <98%
- 98%–99%
- 99%
The majority of the market prefers the 98%–99% purity grade, which balances cost with efficacy. High-purity (>99%) variants are used primarily in pharma synthesis and biotech applications where quality is non-negotiable. Lower grades find usage in large-scale agrochemical production where high precision is not essential.
4. By Distribution Channel
- Direct Sales (B2B)
- Distributors & Traders
- Online Chemical Portals
Direct B2B sales dominate due to bulk buying by large pharmaceutical and agrochemical companies. Distributors and traders play a significant role in regions lacking direct access to producers. Online portals are gradually gaining traction for small-scale procurement in academic and research environments.
5. By Region
- Asia-Pacific
- North America
- Europe
- Latin America
- Middle East & Africa
Asia-Pacific leads the market, driven by high production and consumption rates. North America follows due to high pharmaceutical demand, despite being import-reliant. Europe remains a technologically advanced but moderately sized market. Latin America and the Middle East show growing consumption trends tied to agriculture and infrastructure development.